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Abstract 
The syndecan family consists of four distinct
membrane  glycoproteins  in  mammals.
Syndecans control cell proliferation, differenti-
ation, adhesion and migration through partici-
pation in cell-cell interactions, anchorage of
cells  to  the  extracellular  environment,  and
modulation  of  multiple  growth  factors.
Therefore, syndecans may play a pivotal role in
the regulation of cell behaviour depending on
the  cellular  microenvironment.  Here,  we
demonstrate that syndecan-1, syndecan-2 and
syndecan-4 are expressed in fetal membrane
tissue  with  different  immunolocalizations.
Syndecan-1  is  expressed  in  the  amniotic
epithelium, localizing at basolateral cell sur-
faces. Syndecan-2 and syndecan-4, in contrast,
are mostly localized in intracellular compart-
ments,  in  the  extravillous  cytotrophoblastic
cells and in some fibroblasts of the chorionic
plate as well as in the amniotic epithelial cells.
In the latter, syndecan-4 is mainly localized in
the apical part of the cells. Our results strong-
ly suggest a key role of syndecan-1, syndecan-2
and syndecan-4 in the determination of struc-
tural and functional characteristics of human
amnion and chorionic plate. Since the solute
exchanges  between  fetus  and  mother  take
place  in  fetal  membranes,  our  data  suggest
that  syndecans  are  important  players  in  the
placenta  for  the  establishment  of  the  fetal-
maternal inter-communication.
Introduction
The fetal membranes (chorioamnion) form
a highly specialized interface between mother
and fetus, which is necessary for the success-
ful maintenance and termination of pregnancy
in higher-level vertebrates.
1
The chorioamnion forms the outer limits of
the  sac  that  encloses  the  foetus  while  the
innermost  layer  of  the  sac  is  the  amniotic
membrane  (amnion).
2 The  human  amnion
consists  of  the  amniotic  epithelium,  a  one-
layer cluster of polygonal flattened cells with a
rectangular to hexagonal top surface, a thick
basement  membrane  and  an  avascular  stro-
ma.
3 The amniotic epithelium takes part in the
regulation of the maternal-fetal exchange and
secrets lipid droplets, glycoproteins and pro-
teoglycans  at  the  cell  apex.
4 The  amnion  is
loosely attached to the next layer, the chorion-
ic plate, a tough fibrous tissue layer from the
outer surface of which the villous trees origi-
nate. The amnion and the chorion provide a
large surface area for the potential transfer of
both  water  and  low-molecular-mass  sub-
stances (i.e. glucose, urea) and may play an
important role in the regulation of amniotic
fluid balance. The intercellular spaces and the
extracellular  matrix  are  responsible  for  the
permeability  of  the  fetal  membranes  that
allows  diffusion  of  substrates  to  occur  from
mother to fetus, and viceversa.
2
Syndecans are transmembrane heparan sul-
fate  proteoglycans  (HSPGs),  which  are
expressed in a developmentally regulated and
tissue-specific manner and play a pivotal role
in cell adhesion, migration, proliferation and
differentiation.
5 They  act  as  co-receptors  for
growth factors, participate in signalling during
cell adhesion, modulate the activity of a broad
range of molecules, and partake in many devel-
opmental and pathological processes, includ-
ing  tumorigenesis  and  wound  repair.
6-10 In
mammals, the syndecan family consists of the
products  of  four  distinct  syndecan  genes.
11
Syndecan-1 is mainly limited to epithelial cells,
but several studies indicate that it is also tran-
siently expressed in mesenchymal cells during
embryonic development.
12,13 Consistent with a
role in adhesion, syndecan-1 is present in a
basolateral  distribution  in  epithelia,  and  it
appears  to  regulate  epithelial  morphology.
14
Several  lines  of  evidence  support  the  close
association  between  basic  fibroblast  growth
factor (bFGF) function and syndecan-1 expres-
sion, syndecan-1 mediating bFGF binding and
activity.
15Fibroglycan or syndecan-2 is the most
abundant syndecan of mesenchymal cells.
6,8,16
Its  expression  is  developmentally  regulated.
Expression is low in the early embryonic stage,
culminates during morphogenesis and persists
in some connective tissue cells of the adult.
16
Syndecan-2 is highly expressed in fibroblasts
and endothelial cells, and is involved in cell
adhesion,  proliferation,  angiogenesis  and
matrix assembly.
17,18
Syndecan-3 has essentially been described in
brain  development.
19 Consistent  with  a  more
limited expression, syndecan-3 is absent in the
human placenta.
8 Amphiglycan or syndecan-4 is
expressed in most tissues, but particularly in
liver and kidney, where it localizes on the entire
plasma membrane of various types of epithelial
and fibroblastic cells.
10,20 It is mainly involved in
cell-matrix attachment,
21 increasing focal adhe-
sion formation and decreasing cell motility.
22
Given that the amnion and chorionic plate
play  a  key  role  in  the  inter-communication
between fetus and mother and considering the
multi-faceted role of syndecans in cell-cell and
cell-matrix interactions, we analyzed syndecan
expressions by immunohistochemistry in the
chorionic plate and amniotic epithelium. We
show here, for the first time, that syndecan-1,
syndecan-2 and syndecan-4 are expressed in
human  fetal  membranes  with  different
immunolocalizations.
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Materials and Methods
Tissue preparation
Fourteen human placentas aged 38 (n=6)
and 40 (n=8) weeks of gestation were collect-
ed from clinically normal pregnancies termi-
nated by cesarean sections. One to four speci-
mens were excised from each placenta. The
study  was  approved  by  the  Regional  Ethics
Committee  and  informed  consent  was
obtained from all patients.
Each specimen included the full thickness of
the placenta i.e. from the chorionic to the basal
plate. Specimens were fixed overnight in 4%
neutral buffered formalin at 4°C, then routine-
ly processed for paraffin embedding at 56°C, as
previously  described.
23 Paraffin  sections 
(3 mm) were cut and stretched at 45°C, allowed
to dry and stored at 4°C until use. 
Immunohistochemistry
Immunohistochemistry for syndecans (1-4)
was  performed  as  previously  described.
8
Briefly, paraffin sections were deparaffinated
and rehydrated via xylene and a graded series
of ethyl alcohol. Sections were rinsed in PBS
and incubated with 3% H2O2 in methanol for 30
min to inhibit endogenous peroxidase activity.
Non-specific  antibody  binding  was  blocked
with 3% BSA in PBS for 30 min. Afterwards, the
sections were incubated for 45 min at room
temperature with one of the monoclonal pri-
mary antibodies (Table 1). After washing in
three changes of PBS, the sections were sub-
sequently  incubated  with  biotinylated  anti-
mouse  antibody  (Vector  Laboratories,
Burlingame,  CA,  USA).  The  peroxidase  ABC
method (Vector Laboratories) was performed
for  1  h  at  room  temperature,  using  3’,3’
diaminobenzidine  hydrochloride  (Sigma,  St
Louis, MO, USA) as chromogen.
Sections  were  counterstained  in  Mayer’s
haematoxylin,  rinsed  with  distilled  water,
dehydrated and mounted with Eukitt solution
(Kindler GmbH and Co., Freiburg, Germany).
Negative controls were implemented by replac-
ing  the  primary  antibody  with  PBS.  Further
controls were performed by omitting the sec-
ondary antibody and using an isotype control
antibody. The negative controls confirmed the
specificity  of  the  immunolabeling  obtained
with the primary antibodies. Normal bladder
tissue was used as positive control for synde-
can-3.
10
Results
The immunolabeling of each syndecan has
similar localization and intensity in all four-
teen human placentas. The amniotic epithelial
cells  were  immunolabeled  for  syndecan-1  at
their basolateral surface (Figure 1 a,b). The
extravillous cytotrophoblastic cells underlying
chorionic mesoderm as well as connective tis-
sue cells of the chorionic plate were negative
for syndecan-1. A strong staining pattern for
syndecan-2 was localized in the cytoplasm of
the  amniotic  epithelium,  in  the  extravillous
cytotrophoblastic cells and in some connective
fibroblast cells of the chorionic plate (Figure 1
c). Syndecan-3 was not detectable, neither in
the chorionic plate, nor in the amniotic epithe-
lium. On the contrary, the extravillous cytotro-
phoblastic cells, some fibroblasts of the con-
nective tissue and the amniotic epithelial cells
were immunoreactive for syndecan-4 (Figure 1
d,e). The immunostaining was mainly intra-
cellular, however in amniotic epithelial cells an
intense immunoreactivity was localized at the
apical part of the cells (Figure 1 d,e).
Discussion
Syndecans function as co-receptors, modu-
lating the activity of primary receptors at the
cell surface, by binding a variety of growth fac-
tors and extracellular matrix components via
covalently linked heparan sulfate chains pres-
ent in their ectodomain. Through these inter-
actions, syndecans play various roles in cell-
matrix and cell-cell adhesion, migration, and
proliferation. The binding of cells to the extra-
cellular matrix molecules via syndecans and
matrix receptors may regulate cell morphology
and influence cell behaviour through the inter-
action  of  ligated  receptors  and  co-receptors
with cytoplasmic molecules. In fact, this inter-
action allows the signal transduction through
the plasma membrane, resulting in intracellu-
lar changes and alterations in gene expression
that lead to the regulation of cell differentia-
tion.
24 Because alterations in syndecan expres-
sions  enable  cells  to  become  more  or  less
responsive  to  their  micro-environment  and
considering the important exchange processes
that take place between the amniotic fluid and
the  maternal  compartment,  the  aim  of  our
study was to analyze the expression of synde-
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Table 1. Antibodies used in this study.
Antibodies Specificity Ab conc Reference
mAb B-B4 Syndecan-1 1:60 (v/v) Serotec, Oxford, UK
(ectodomain)
mAb 10H4 Syndecan-2 20-30 mg/mL Lories et al.,198935
(ectodomain)
mAb 1C7 Syndecan-3 2-3 mg/mL Lories et al., 198935
(ectodomain)
mAb 8G3 Syndecan-4 50-100 mg/mL Lories et al., 198935
(ectodomain)
mAb, monoclonal antibody.
Figure 1. Paraffin sections of term placen-
tas. (a) Immunohistochemical localization
of syndecan-1 using the antibody B-B4. (b)
Shows a high magnification of the squared
area depicted in panel a. Cellular plasma-
membrane of amniotic epithelium shows
an evident immunostaining in the basolat-
eral compartment. (c) Immunostaining for
syndecan-2 with the antibody 10H4. The
amniotic  epithelium  and  the  trophoblast
(arrows) underneath the amnion are posi-
tive  in  the  cytoplasm.  (d).  Immuno  -
reactivity  of  syndecan-4  revealed  by  the
antibody 8G3. Arrows indicate immunos-
tained extravillous cytotrophoblastic cells.
(e)  Shows  a  high  magnification  of  the
squared  area  depicted  in  panel  (d)  The
staining  is  localized  in  the  intracellular
compartment of amniotic epithelium but
it is more intense at the apex of the epithe-
lial cells.
a,c,d: Bar=90 mm; b,e: Bar=25 mm.[European Journal of Histochemistry 2010; 54:e42] [page 199]
cans  in  amniotic  epithelium  and  chorionic
plate of human placenta.
Our results indicate that syndecan-3 is not
detectable, according with previous data that
demonstrate the absence of this molecule in
human placenta.
8 Instead, syndecan-2 and syn-
decan-4 were primarily localized in the intra-
cellular  compartment,  whereas  syndecan-1
was expressed on the plasma membrane. The
differential  localization  of  syndecans  may
reflect different roles of these molecules with-
in  amniotic  epithelium  and  chorionic  plate.
Syndecans may be involved in maintaining the
morphology and the organization of the cells
through their interactions with the cytoskele-
ton. This is supported by evidence that trans-
membrane and cytoplasmic domains of synde-
cans  can  associate  with  and  reorganize
cytoskeletal actin, resulting in changes in cel-
lular shape and structure.
25 Interestingly, syn-
decan-2 and syndecan-4 were mostly localized
inside cells, both in the amniotic epithelium
and in the extravillous cytotrophoblastic cells
of the chorionic plate. This localization may
have a structural function, suggesting a poten-
tial contribution of syndecan-2 and syndecan-4
to  the  tensile  strength  of  fetal  membranes,
thereby supporting the resistance of placenta
against over-distension.
Syndecan-2 and syndecan-4 are transmem-
brane  proteoglycans  that  support  integrin-
mediated  cell-matrix  and  cell-cell  adhesion.
7
Both syndecan-2 and syndecan-4 are particu-
larly abundant in sites where several cell-cell
and  cell-matrix  interactions  are  known  to
occur.
4 In  this  context,  these  two  syndecans
may also regulate both the active transport of
solute by the amnion into the amniotic space
and passive water diffusion, directly or by mod-
ifying  cell-cell  and  cell-matrix  contacts.  The
cell-matrix adhesion is also regulated by the
formation of focal adhesions, macromolecular
structures through which the cell attaches to
the  extracellular  matrix.
26 In  addition,  many
cellular responses to ligands are also stimulat-
ed  by  the  formation  of  focal  adhesions.
27
Studies  have  revealed  that  syndecan-4  is  a
focal  adhesion  component  which  may  both
localize protein kinase C and amplify its activ-
ity at sites of adhesion formation.
28,29 Therefore,
the  syndecan-4  localization  at  the  apex  of
amniotic epithelial cells could underline a cru-
cial  role  of  this  molecule  in  the  sensing  of
amniotic fluid environment.
In contrast, syndecan-1 was detected at the
basolateral plama membrane of the amniotic
epithelial  cells,  however  was  absent  in  the
extravillous cytotrophoblastic cells and connec-
tive  tissue  cells  of  the  chorionic  plate.  This
immunolocalization is compatible with the fact
that syndecan-1 is expressed predominantly in
epithelial cells and uniquely restricted to the
basolateral surface. This would promote cell-
cell adhesion, maintaining the epithelial phe-
notype  and  organization.
30-33 Down-regulation
of  syndecan-1  causes  epithelial  cells  to  lose
their cuboidal morphology, migrate and grow
independent  of  anchorage.
32 It  is  intriguing
that  syndecan-1  shows  a  different  cellular
localization depending on the placenta com-
partments. In fact, the syncytiotrophoblast of
human chorionic villi expresses syndecan-1 on
the apical surface and not in the basolateral
one.
8 This  peculiar  staining  pattern  likely
reflects the role of syndecan-1 in the active
communication between fetal villi and mater-
nal blood. Syndecan-1 acts as co-receptor for
bFGF allowing the binding of the growth factor
to its signalling receptor on the plasma mem-
brane.
34 Syndecan-1 clearly plays a part in reg-
ulating the signal transduction pathways that
transmit the extracellular signal of bFGF into
the nucleus. Previous studies suggest that cer-
tain substances could be transported toward
the  amnion  from  the  underlying  trophoblast
layer  of  the  fetal  membranes  and  chorionic
plate.
3 In  amniotic  epithelium,  the  potential
basolateral  bFGF  signal  coming  from  the
underlying  layers
23 probably  takes  place  in
order to permit the amnion extension during
placenta development. On the other hand, in
the syncytiotrophoblast, the apical bFGF sig-
nalling from mother is likely required for the
growth of the fetal villous tree. 
In conclusion, this is the first report that
analyses  the  expression  of  syndecans  in
human fetal membranes. Our results strongly
suggest a key role of syndecan-1, syndecan-2
and syndecan-4 in the determination of struc-
tural and functional characteristics of human
amnion and chorionic plate. 
These new data are useful to improve the
understanding  of  the  basic  components  of
human fetal membranes, in order to shed light
on both the normal biology and pathobiology of
these tissues, which is crucial for the eventual
control  of  some  pregnancy  complication  as
preterm labor.
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